Morgan Stanley analyst Sarah Lester downgraded Centrica (CPYYY) to Equal Weight from Overweight with a price target of 215 GBp, up from 210 GBp. While the firm sees “an attractive evolution in Centrica’s business mix” catalyzing double-digit EPS growth in 2029-30, it cites a strong run with shares up 20% since September, completion of the buyback without extension, and a lack of near-term catalysts for its downgrade.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPYYY:
- Centrica downgraded to Hold from Buy at Jefferies
- Centrica: Fairly Valued With Limited Near-Term Catalysts and Unclear Post-2028 Growth, Justifying a Hold Rating
- Centrica price target raised to 232 GBp from 205 GBp at Goldman Sachs
- Centrica price target raised to 225 GBp from 215 GBp at RBC Capital
- Centrica price target raised to 224 GBp from 203 GBp at JPMorgan